Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers. [electronic resource]
Producer: 20140627Description: 44 p. digitalISSN:- 2050-6511
- Adult
- Aged
- Aged, 80 and over
- Amputation, Surgical -- statistics & numerical data
- Diabetic Foot -- drug therapy
- Dose-Response Relationship, Drug
- Epidermal Growth Factor -- administration & dosage
- Female
- Granulation Tissue -- drug effects
- Humans
- Injections, Intralesional
- Male
- Middle Aged
- Product Surveillance, Postmarketing
- Prospective Studies
- Treatment Outcome
- Wound Healing -- drug effects
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.